Israeli Settlements Exceed Boundaries, Report Says A report says that 90 percent of the settlements in the West Bank sprawl beyond their official boundaries.... Read Full Article Godfather Of Soul; Father Many Times Over Since the death of James Brown, about a dozen people have asked for DNA tests to determine if the late singer was their father.... Read Full Article Those Sturdy Old Songs, Without Benefit Of A Band Steve Earle called himself a ?recovering folk singer? at Town Hall on Wednesday, and luckily the recovery is far from complete.... Read Full Article In 2007, Some Giants Went Smaller Bigger is better, right? Not so fast. Corporate America appears to have had second thoughts in 2007.... Read Full Article KGB Defector Fears He Will Be Next Alexander Litvinenko OLEG GORDIEVSKY, the former KGB officer who spied for Britain, fears he could be murdered by Russians in this country.... Read Full Article |
Merck Reports Risk Of Its New Pain PillWASHINGTON, April 10 — A study by Merck of its pain reliever Arcoxia showed similar risks of heart attacks and other cardiovascular problems compared with another painkiller, diclofenac, federal reviewers said in an analysis made public Tuesday. Diclofenac, sold under names including Voltaren and Voltarol, is considered by some cardiologists to be among the most dangerous of standard arthritis treatments in terms of heart safety. The Food and Drug Administration staff summary also noted that Arcoxia patients quit the study at a higher rate because of complications related to high blood pressure. Arcoxia is Mercks successor to Vioxx pill, which was withdrawn. Arcoxia is sold in 63 countries, and Merck is seeking F.D.A. approval for American sales . An advisory panel of experts from outside the F.D.A. is meeting Thursday to consider approving Arcoxia. Tag CloudExternal InformationAdditional InformationAlastair Darling plans to control future crises...Dixon ready to disembark Qantas seat... Gems in the Back of a Closet... Take careers advice with pinch of salt... Where Am I?News Main Page - Business - Merck Reports Risk Of Its New Pain Pill |
i8news.com |